Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 3Unknown 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Rectal Neoplasms 3Recurrence 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × OTHER × Transanal Endoscopic Surgery × Clear all
NCT03959839 2025-06-03

DSETAMIS2018

Puerta de Hierro University Hospital

Phase NA Completed
70 enrolled
Gastrointestinal

Rectal Neoplasms, Recurrence

NCT01340755 2017-09-06

Laparoscopy-Assisted Transanal Endoscopy Rectosigmoid Resection for Rectal Cancer

Massachusetts General Hospital

Phase NA Completed
5 enrolled
Gastrointestinal

Rectal Neoplasms

NCT02626728 2016-11-22

TAMIS

Hvidovre University Hospital

Completed
25 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡